Exact Mass: 298.143
Exact Mass Matches: 298.143
Found 233 metabolites which its exact mass value is equals to given mass value 298.143,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Trimeprazine
Trimeprazine is only found in individuals that have used or taken this drug. It is a phenothiazine derivative that is used as an antipruritic. [PubChem]Trimeprazine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D003879 - Dermatologic Agents > D000982 - Antipruritics
Toxin T2 tetrol
T-2 Tetraol is a type-A trichothecene mycotoxin produced by different Fusarium species, including F. soprotrichioides, F. poae, and F. acuinatum that contaminate feedstuffs and cereal grains (PMID: 11843402, 31683661). T-2 Tetraol shows the highest toxicity in animals compared to other trichothecenes. It contains a tetracyclic sesquiterpenoid 12,13-epoxytrichothec-9-ene ring which is responsible for the high toxicological activity (PMID: 12749813). In T-2 Tetraol, a carbonyl group at the C-8 position is substituted by an ester. T-2 Tetraol is resistant to light and temperature, but sensitive to strong acid or alkaline conditions. Some coexisting bacteria or fungi can detoxify T-2 Tetraol by altering its structure. It is associated with a wide range of effects in animals including weight loss, diarrhea, lethargy, low plasma glucose, decreases in blood cell and leukocyte count. damage to cartilaginous tissues, and induction of apoptosis (PMID: 21417259). D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins Mycotoxin from Fusarium poae and Fusarium sporotrichioides
3,7,8,15-Scirpenetetrol
3,7,8,15-Scirpenetetrol is a mycotoxin from Fusarium graminearum. Mycotoxin from Fusarium graminearum
Nialamide
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AF - Monoamine oxidase inhibitors, non-selective D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
Piribedil
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist Piribedil is a potent and orally active dopamine D2 and dopamine D3 agonist. Piribedil is also a α2-adrenoceptors antagonist. Piribedil can inhibit MLL1 methyltransferase activity (EC50: 0.18 μM). Piribedil has the potential for the research of parkinson's disease, circulatory disorders, cancers[1][2][3][4].
N1-Acetyl-2-cyano-3-(4-phenylpiperazino)acrylamide
Nialamide
N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AF - Monoamine oxidase inhibitors, non-selective D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
Hydroheptilidic-acid
[Raw Data] CBA58_Hydrohepteli_pos_50eV.txt [Raw Data] CBA58_Hydrohepteli_pos_40eV.txt [Raw Data] CBA58_Hydrohepteli_pos_30eV.txt [Raw Data] CBA58_Hydrohepteli_pos_20eV.txt [Raw Data] CBA58_Hydrohepteli_pos_10eV.txt
1-alpha-hydroxy-3-deoxypseudoanisatin|1alpha-hydroxy-3-deoxypseudoanisatin|1??-Hydroxy-3-deoxypseudoanisatin
4E-1beta-hydroperoxy-3beta,11beta-dihydroxygermacra-4(5),10(14)-dien-12,6alpha-olide
rel-5-(1R,5S-dimethyl-3R,4R,8S-trihydroxy-7-oxabicyclo[3,2,1]oct-8-yl)-3-methyl-2Z,4E-pentadienoic acid
2-isopropyl-5-methyl-p-hydroquinone-4-O-beta-xylopyranoside
1alpha-hydroxy-6-deoxypseudoanisatin|1??-Hydroxy-6-deoxypseudoanisatin
(3-Phenyl-propyl)-beta-D-glucopyranosid|(3-phenyl-propyl)-beta-D-glucopyranoside|3-phenyl-1-propanol beta-D-glucopyranoside|3-phenylpropan-1-ol beta-D-glucopyranoside|3-phenylpropyl beta-D-glucopyranoside
(2R,2aR,4aS,5R,8R,8aS,8bS,9S)-octahydro-2,2a-dihydroxy-9-(2-hydroxy-1-methylethyl)-8b-methyl-5,6-methano-1,7dioxacyclopent[cd]azulen-6(2H)-one|dendronobilin C
3alpha-hydroxy-5beta-(4-hydroxytigloyloxy)-7-hydroxycarvotanacetone
(2aR,10aS)-3t,4,10t-Trihydroxy-2a,3c,8c-trimethyl-(2ar)-hexahydro-4c,7ac-methano-cyclopent[b]oxeto[2,3-c]oxocin-6-on|(2aR,10aS)-3t,4,10t-trihydroxy-2a,3c,8c-trimethyl-(2ar)-hexahydro-4c,7ac-methano-cyclopent[b]oxeto[2,3-c]oxocin-6-one
2-(Dimethylamino)-5-(1H-indole-3-yl)-5-(2-oxopropyl)-2-imidazoline-4-one
7,9,10-trihydroxy-4-oxobisabol-2,11-dien-13-oic acid
3-deoxy-10alpha(14)-epoxy-11alpha,13-dihydroxy-11,13-dihydroamphoricarpolide
3-(3,4,5-Trimethoxyphenyl)-3-methoxy-1-propanol acetate
3-hydroxy-4-(2,6,7-trihydroxy-6-methylheptan-2-yl)benzoic acid
C15H22O6_(2E)-3-[(3aS,4S,5R,7aS)-7a-Hydroxy-5-isopropyl-3-oxooctahydro-2-benzofuran-4-yl]-2-(hydroxymethyl)acrylic acid
C15H22O6_(3beta,4alpha,8alpha)-12,13-Epoxytrichothec-9-ene-3,4,8,15-tetrol
C15H22O6_Methyl 2-(1,3,5-trihydroxy-4a-methyl-8-oxodecahydro-2-naphthalenyl)acrylate
[2-[(E)-3,4-dihydroxypent-1-enyl]-6-oxooxan-3-yl] (E)-2-methylbut-2-enoate
methyl 2-(1,3,5-trihydroxy-4a-methyl-8-oxo-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl)prop-2-enoate
T-2 Tetraol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE isolated standard
trimeprazine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AD - Phenothiazine derivatives C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic D003879 - Dermatologic Agents > D000982 - Antipruritics
T-2 Tetraol
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins
methyl 2-(1,3,5-trihydroxy-4a-methyl-8-oxo-1,2,3,4,5,6,7,8a-octahydronaphthalen-2-yl)prop-2-enoate_major
[2-[(E)-3,4-dihydroxypent-1-enyl]-6-oxooxan-3-yl] (E)-2-methylbut-2-enoate_major
Idebenone Metabolite (Benzenehexanoic acid, 2,5-dihydroxy-3,4-dimethoxy-6-methyl-)
3,7,8,15-Scirpenetetrol
Methyl 2-(1,3,5-trihydroxy-4a-methyl-8-oxodecahydro-2-naphthalenyl)acrylate
(3S,6S,8AS)-6-((TERT-BUTOXYCARBONYL)AMINO)-5-OXOOCTAHYDROINDOLIZINE-3-CARBOXYLIC ACID
diethazine
C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent
4-TRIFLUOROMETHYL-TRANS-BETA-STYRYLBORONIC ACID PINACOL ESTER
BENZYL 2-PROPYLPIPERAZINE-1-CARBOXYLATE HYDROCHLORIDE
2-[2-[4-(dimethylamino)phenyl]ethenyl]-5-nitrobenzene-1,4-diamine
E-2-(3-Trifluoromethylphenyl)vinylboronic acid pinacol ester
Vortioxetine
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D049990 - Membrane Transport Modulators Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Vortioxetine is a inhibitor of 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT, with Ki values of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.
4-(4-phenylphenyl)-2,3-dihydro-1H-1,5-benzodiazepine
piprozolin
C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy
tert-butyl 4-[4-(hydroxymethyl)-1,3-thiazol-2-yl]piperidine-1-carboxylate
methyl N-[(3R,4R)-1-benzyl-4-methylpiperidin-3-yl]carbamate
2-[1,4]Diazepan-1-yl-5-propyl-benzenesulfonic acid
5-tert-butylsulfonyl-2-piperidin-1-ylpyrimidin-4-amine
N-cyclopentyl-2-methyl-5-(3-nitrophenyl)pyrimidin-4-amine
N-cyclopentyl-2-methyl-5-(4-nitrophenyl)pyrimidin-4-amine
2-trifluoromethyl-trans-beta-styrylboronic acid pinacol ester
1-(4-Fluorophenyl)-5-methyl-2-phenylhexane-1,4-dione
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-naphthoic acid
6-Methoxypyridine-2-boronic acid N-phenyldiethanolamine ester
4-ETHYLAMINO-PIPERIDINE-1-CARBOXYLIC ACID BENZYL ESTER-HCl
benzyl (2R)-2-propan-2-ylpiperazine-1-carboxylate,hydrochloride
benzyl (2R)-2-propylpiperazine-1-carboxylate,hydrochloride
benzyl (2S)-2-propylpiperazine-1-carboxylate,hydrochloride
(E)-2-(Hydroxymethyl)-3-[(3aalpha)-3-oxo-5beta-isopropyl-7aalpha-hydroxyoctahydroisobenzofuran-4alpha-yl]acrylic acid
Isopropyl 2-amino-5-[(diethylamino)carbonyl]-4-methylthiophene-3-carboxylate
(2S)-5-(dimethylamino)-9-methyl-2-prop-2-enylpyrazolo[1,2-a][1,2,4]benzotriazine-1,3-dione
Piribedil
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents N - Nervous system > N04 - Anti-parkinson drugs > N04B - Dopaminergic agents > N04BC - Dopamine agonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist Piribedil is a potent and orally active dopamine D2 and dopamine D3 agonist. Piribedil is also a α2-adrenoceptors antagonist. Piribedil can inhibit MLL1 methyltransferase activity (EC50: 0.18 μM). Piribedil has the potential for the research of parkinson's disease, circulatory disorders, cancers[1][2][3][4].
Neopinone(1+)
The trialkylammonium ion resulting from the protonation of the amino group of neopinone.
N-propanoyl-gamma-L-glutamyl-L-orornithine-delta-lactam
(5R,6S)-3-(5-azaniumyl-2-methylpentan-2-yl)-6-[(1R)-1-hydroxyethyl]-7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylate
(5R,6S)-3-(5-amino-2-methylpentan-2-yl)-6-[(1R)-1-hydroxyethyl]-7-oxo-4-oxa-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
2-imino-10-propyltetrahydro-8a,3-(epoxymethano)chromene-3,4,4(2H,4aH)-tricarbonitrile
N-[6-(1-oxopentylamino)-3-pyridinyl]-3-pyridinecarboxamide
N-(4-{[2-(1H-pyrrol-2-ylmethylene)hydrazino]carbonyl}phenyl)butanamide
2-{4-[3-(5-Methyl-2-furyl)acryloyl]-1-piperazinyl}pyrimidine
5-Methyl-N-[4-(4-morpholinyl)phenyl]-2-pyrazinecarboxamide
N-[4-methyl-6-(1-oxobutylamino)-3-pyridinyl]-4-pyridinecarboxamide
2-[[2-(4-Methoxyphenyl)-5-methyl-7-pyrazolo[1,5-a]pyrimidinyl]amino]ethanol
(4bS,6aS,9aS,9bR)-6a-methyl-7-oxo-5,6,6a,7,8,9,9a,9b,10,11-decahydro-4bH-indeno[5,4-f]quinoline-2-carboxylate
(6E)-6-(naphthalen-2-ylmethylidene)-8,9-dihydro-7H-benzo[7]annulen-5-one
3-Hydroxy-4-(2,6,7-trihydroxy-6-methylheptan-2-yl)benzoic acid
8,9-Diphenyltricyclo(5,2,1,0(2,6))deca-4,8-dien-3-one
(4S)-N-[1-(Methoxycarbonyl)-3-butenyl]-2-oxo-4beta-(tert-butyl)oxazolidine-3-carboxamide
oripavine(1+)
The trialkylammonium ion resulting from the protonation of the amino group of oripavine; Major species at pH 7.3.
pyridinestrone-3-carboxylate
A steroid acid anion, that is the conjugate base of pyridinestrone-3-carboxylic acid. An abiotic metabolite in the 4,5-seco pathway of aerobic estrogen degradation by the bacterium Sphingomonas sp. strain KC8.
p-Ts-L-Lys-Me
A methyl ketone that is L-lysine with an alpha-amine hydrogen substituted with a 4-methylbenzenesulfonamide (tosyl) group and a methyl group replacing the hydroxy of the carboxylic acid.
(3s,3as,6r,7s,8r,8ar)-6,8-dihydroxy-3,6,8-trimethyl-tetrahydro-3h-spiro[cyclohepta[b]furan-7,2'-oxolane]-2,5'-dione
5,9,11,13-tetrahydroxy-2,6,10-trimethyl-8-oxatetracyclo[7.3.1.0¹,⁵.0⁶,¹⁰]tridecan-4-one
(1s,2r,4r,6r,7r,8s,9r,12s)-2,8-dihydroxy-6-(hydroxymethyl)-12-isopropyl-7-methyl-5,10-dioxatetracyclo[7.2.1.0²,⁷.0⁴,⁶]dodecan-11-one
7-hydroperoxy-3,9-dihydroxy-3,10-dimethyl-6-methylidene-3ah,4h,5h,7h,8h,9h,11ah-cyclodeca[b]furan-2-one
4,5,7,9-tetrahydroxy-4a,8-dimethyl-3-methylidene-octahydro-3ah-azuleno[6,5-b]furan-2-one
3,4,6-trihydroxy-6-(4-methyl-5-oxocyclohex-3-en-1-yl)-2-methylideneheptanoic acid
(1r,2r,5r,7s,10s)-10-hydroperoxy-2-isopropyl-5-methyl-11,12-dioxatricyclo[5.3.2.0¹,⁵]dodec-8-ene-8-carboxylic acid
4',6,7-trihydroxy-6',7-dimethyl-1,4,5,6-tetrahydrospiro[2-benzopyran-3,2'-oxan]-8-one
(2r)-2,3-dihydroxy-2-(2-hydroxy-5-methoxy-4-methylphenyl)propyl 2-methylpropanoate
2',5,6-trihydroxy-2',4,4'-trimethyl-3'a,4',5',7'a-tetrahydrospiro[cyclohexane-1,3'-furo[2,3-c]pyra]-3-en-7'-one
(3r,4's,6r,6's,7r)-4',6,7-trihydroxy-6',7-dimethyl-1,4,5,6-tetrahydrospiro[2-benzopyran-3,2'-oxan]-8-one
2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-ene-3',4',10'-triol
(1's,2'r,4's,7'r,9'r,10'r,11's)-2'-(hydroxymethyl)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-ene-4',10',11'-triol
1α-hydroxy-3-deoxypseudoanisatin
{"Ingredient_id": "HBIN002307","Ingredient_name": "1\u03b1-hydroxy-3-deoxypseudoanisatin","Alias": "NA","Ingredient_formula": "C15H22O6","Ingredient_Smile": "CC1C(=O)CC23CC(=O)OCC1(C2(C(CC3(C)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9988","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1α-hydroxy-6-deoxypseudoanisatin
{"Ingredient_id": "HBIN002308","Ingredient_name": "1\u03b1-hydroxy-6-deoxypseudoanisatin","Alias": "NA","Ingredient_formula": "C15H22O6","Ingredient_Smile": "CC1C(=O)CC23CC(=O)OCC1(C2(C(CC3(C)O)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9989","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-hydroxy-6-deoxypseudoanisatin
{"Ingredient_id": "HBIN006813","Ingredient_name": "(2s)-hydroxy-6-deoxypseudoanisatin","Alias": "NA","Ingredient_formula": "C15H22O6","Ingredient_Smile": "CC1C(C(C2(C13CC(=O)C(C2(COC(=O)C3)C)C)O)O)O","Ingredient_weight": "298.33 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9990","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "101254353","DrugBank_id": "NA"}
amoenin
{"Ingredient_id": "HBIN015879","Ingredient_name": "amoenin","Alias": "NA","Ingredient_formula": "C15H22O6","Ingredient_Smile": "CC(C)C1C2C(C3(C(C1C(=O)O2)(CC4C3(O4)CO)O)C)O","Ingredient_weight": "298.33","OB_score": "NA","CAS_id": "70219-71-5","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "6835","PubChem_id": "101967060","DrugBank_id": "NA"}
